As of January 23, 2025, Bellerophon Therapeutics (BLPH) has a market cap of $146,792 Dollars USD. According to our data, Bellerophon Therapeutics is ranked No.9303 in global market value.
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
United Therapeutics
UTHR
|
$16.58 B |
-0.000 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Market Cap | = | BLPH Stock Price | * | BLPH Shares Outstanding |
= | $0.01 | * | 12.23 M | |
= | $146,792 Dollars |